Brooklyn FI LLC Invests $5.82 Million in Agilent Technologies, Inc. (NYSE:A)

Brooklyn FI LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 42,496 shares of the medical research company's stock, valued at approximately $5,822,000.

A number of other institutional investors have also recently bought and sold shares of A. CKW Financial Group raised its position in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after acquiring an additional 100 shares in the last quarter. Global X Japan Co. Ltd. grew its stake in shares of Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Hanson & Doremus Investment Management grew its stake in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after buying an additional 105 shares in the last quarter. OFI Invest Asset Management acquired a new stake in Agilent Technologies during the fourth quarter worth about $37,000. Finally, RPg Family Wealth Advisory LLC acquired a new stake in Agilent Technologies during the third quarter worth about $38,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Remove Ads

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on A. Barclays upgraded shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and raised their price objective for the company from $135.00 to $145.00 in a report on Monday, February 10th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a report on Thursday, February 27th. Sanford C. Bernstein lowered their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating for the company in a report on Tuesday, November 26th. Bank of America reduced their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Finally, Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $146.15.

Agilent Technologies Stock Up 0.4 %

NYSE:A traded up $0.44 during trading hours on Friday, hitting $120.72. 3,041,425 shares of the company traded hands, compared to its average volume of 1,684,549. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm's 50-day simple moving average is $136.74 and its 200-day simple moving average is $137.29. Agilent Technologies, Inc. has a one year low of $117.17 and a one year high of $155.35. The company has a market cap of $34.42 billion, a PE ratio of 27.75, a PEG ratio of 3.39 and a beta of 1.11.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Equities analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies's payout ratio is 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.